Literature DB >> 8883399

Colocalisation of matrix metalloproteinase-9-mRNA and protein in human colorectal cancer stromal cells.

Z S Zeng1, J G Guillem.   

Abstract

The matrix metalloproteinases (MMPs) are perceived as essential for tumour invasion and metastases. The purpose of this study was to determine the expression and cellular localisation of the 92 kDa type IV collagenase (MMP-9) protein and mRNA in human colorectal cancer (CRC). In CRC and matched normal mucosa specimens from 26 CRC patients, Northern blot hybridisation and Western blot analyses provide convincing evidence that MMP-9 is expressed in greater quantities in CRC than in normal tissue. The MMP-9 tumour to normal mucosa fold-increase (T/N) was 9.7 +/- 7.1 (mean +/- s.d.) (P < 0.001) for RNA and 7.1 +/- 3.9 (P < 0.001) for protein. The sites of MMP-9 mRNA and protein synthesis were colocalised in tumour stroma by in situ hybridisation and immunohistochemistry in 26 CRC samples. Both MMP-9 mRNA and protein signals were strongest in the population of stromal cells concentrated at the tumour-stroma interface of an invading tumour. Furthermore, MMP-9-positive cells were identified as macrophages using an antimacrophage antibody (KP1) in serial sections from ten CRC samples. Given the persistent localisation of MMP-9-producing macrophages to the interphase between CRC and surrounding stroma, our observations suggest that MMP-9 production is controlled, in part, by tumour-stroma cell interactions. Further studies are needed to determine the in vivo regulation of MMP-9 production from infiltrating peritumour macrophages.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8883399      PMCID: PMC2075925          DOI: 10.1038/bjc.1996.511

Source DB:  PubMed          Journal:  Br J Cancer        ISSN: 0007-0920            Impact factor:   7.640


  57 in total

1.  KP1: a new monoclonal antibody that detects a monocyte/macrophage associated antigen in routinely processed tissue sections.

Authors:  K A Pulford; E M Rigney; K J Micklem; M Jones; W P Stross; K C Gatter; D Y Mason
Journal:  J Clin Pathol       Date:  1989-04       Impact factor: 3.411

2.  Tumor promoter-stimulated Mr 92,000 gelatinase secreted by normal and malignant human cells: isolation and characterization of the enzyme from HT1080 tumor cells.

Authors:  U M Moll; G L Youngleib; K B Rosinski; J P Quigley
Journal:  Cancer Res       Date:  1990-10-01       Impact factor: 12.701

3.  Gelatinases of metastatic cell lines of murine colonic carcinoma as detected by substrate-gel electrophoresis.

Authors:  S Yamagata; Y Ito; R Tanaka; S Shimizu
Journal:  Biochem Biophys Res Commun       Date:  1988-02-29       Impact factor: 3.575

4.  Ras oncogene mediated induction of a 92 kDa metalloproteinase; strong correlation with the malignant phenotype.

Authors:  M Ballin; D E Gomez; C C Sinha; U P Thorgeirsson
Journal:  Biochem Biophys Res Commun       Date:  1988-08-15       Impact factor: 3.575

5.  Expression of collagenase IV (basement membrane collagenase) activity in murine tumor cell hybrids that differ in metastatic potential.

Authors:  T Turpeenniemi-Hujanen; U P Thorgeirsson; I R Hart; S S Grant; L A Liotta
Journal:  J Natl Cancer Inst       Date:  1985-07       Impact factor: 13.506

6.  Influence of organ environment on extracellular matrix degradative activity and metastasis of human colon carcinoma cells.

Authors:  M Nakajima; K Morikawa; A Fabra; C D Bucana; I J Fidler
Journal:  J Natl Cancer Inst       Date:  1990-12-19       Impact factor: 13.506

7.  Increased levels of phorbin, c-myc, and ornithine decarboxylase RNAs in human colon cancer.

Authors:  J G Guillem; M F Levy; L L Hsieh; M D Johnson; P LoGerfo; K A Forde; I B Weinstein
Journal:  Mol Carcinog       Date:  1990       Impact factor: 4.784

8.  Molecular cloning of a novel membrane-type matrix metalloproteinase from a human breast carcinoma.

Authors:  X S Puente; A M Pendás; E Llano; G Velasco; C López-Otín
Journal:  Cancer Res       Date:  1996-03-01       Impact factor: 12.701

9.  Complex regulation of membrane-type matrix metalloproteinase expression and matrix metalloproteinase-2 activation by concanavalin A in MDA-MB-231 human breast cancer cells.

Authors:  M Yu; H Sato; M Seiki; E W Thompson
Journal:  Cancer Res       Date:  1995-08-01       Impact factor: 12.701

10.  A plasma membrane-associated component of ovarian adenocarcinoma cells enhances the catalytic efficiency of matrix metalloproteinase-2.

Authors:  T N Young; S V Pizzo; M S Stack
Journal:  J Biol Chem       Date:  1995-01-20       Impact factor: 5.157

View more
  9 in total

1.  Proteolysis in colorectal cancer.

Authors:  E A Garbett; M W Reed; N J Brown
Journal:  Mol Pathol       Date:  1999-06

2.  Metastatic and non-metastatic colorectal cancer (CRC) cells induce host metalloproteinase production in vivo.

Authors:  S Mc Donnell; V Chaudhry; J Mansilla-Soto; Z S Zeng; W P Shu; J G Guillem
Journal:  Clin Exp Metastasis       Date:  1999-06       Impact factor: 5.150

3.  Quercetin and sulforaphane in combination suppress the progression of melanoma through the down-regulation of matrix metalloproteinase-9.

Authors:  Saurabh J Pradhan; Rosalin Mishra; Priyanka Sharma; Gopal C Kundu
Journal:  Exp Ther Med       Date:  2010-08-26       Impact factor: 2.447

4.  Overexpression of matrix metalloproteinase-21 is associated with poor overall survival of patients with colorectal cancer.

Authors:  Yi Huang; Wenhai Li; Dake Chu; Jianyong Zheng; Gang Ji; Mengbin Li; Hongwei Zhang; Weizhong Wang; Jianjun Du; Jipeng Li
Journal:  J Gastrointest Surg       Date:  2011-05-18       Impact factor: 3.452

5.  Matrix metalloproteinase-9 expression in the normal mucosa-adenoma-dysplasia-adenocarcinoma sequence of the colon.

Authors:  László Herszényi; Ferenc Sipos; Orsolya Galamb; Norbert Solymosi; István Hritz; Pál Miheller; Lajos Berczi; Béla Molnár; Zsolt Tulassay
Journal:  Pathol Oncol Res       Date:  2008-03-18       Impact factor: 3.201

6.  Berberine suppresses TNF-alpha-induced MMP-9 and cell invasion through inhibition of AP-1 activity in MDA-MB-231 human breast cancer cells.

Authors:  Sangmin Kim; Jae Hyuck Choi; Jong Bin Kim; Seok Jin Nam; Jung-Hyun Yang; Jung-Han Kim; Jeong Eon Lee
Journal:  Molecules       Date:  2008-12-03       Impact factor: 4.411

Review 7.  Berberine as a potential agent for breast cancer therapy.

Authors:  Xiao-Dan Zhong; Li-Juan Chen; Xin-Yang Xu; Yan-Jun Liu; Fan Tao; Ming-Hui Zhu; Chang-Yun Li; Dan Zhao; Guan-Jun Yang; Jiong Chen
Journal:  Front Oncol       Date:  2022-09-02       Impact factor: 5.738

8.  Unique activation of matrix metalloproteinase-9 within human liver metastasis from colorectal cancer.

Authors:  Z S Zeng; J G Guillem
Journal:  Br J Cancer       Date:  1998-08       Impact factor: 7.640

9.  Tissue levels of active matrix metalloproteinase-2 and -9 in colorectal cancer.

Authors:  E T Waas; R M L M Lomme; J DeGroot; Th Wobbes; T Hendriks
Journal:  Br J Cancer       Date:  2002-06-17       Impact factor: 7.640

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.